Neutrophils Pretreated with Volatile Anesthetics Lose Ability to Cause Cardiac Dysfunction
- 1 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 98 (3) , 712-718
- https://doi.org/10.1097/00000542-200303000-00020
Abstract
Background: Volatile anesthetics can precondition the myocardium against functional depression and infarction following ischemia-reperfusion. Neutrophil activation, adherence, and release of superoxide play major roles in reperfusion injury. The authors tested the hypothesis that pretreatment of neutrophils with a volatile anesthetic, i.e., simulated preconditioning, can blunt their ability to cause cardiac dysfunction. Methods: Studies were performed in 60 buffer-perfused and paced isolated rat hearts. Left ventricular developed pressure served as an index of myocardial contractility. Polymorphonuclear neutrophils and/or drugs were added to coronary perfusate for 10 min, followed by 30 min of recovery. Platelet-activating factor was used to stimulate neutrophils. Pretreatment of neutrophils consisted of incubation with 1.0 minimum alveolar concentration (MAC) isoflurane or sevoflurane for 15 min, followed by washout. Additional studies were performed with 0.25 MAC isoflurane. Effects of superoxide dismutase were compared to those of volatile anesthetics. Superoxide production was measured by spectrophotometry. Neutrophil adherence to coronary vascular endothelium was estimated from the difference between neutrophils administered and recovered in coronary venous effluent. Results: Activated neutrophils caused marked, persistent reduction (> 50%) in left ventricular developed pressure. Isoflurane and sevoflurane at 1.0 MAC and superoxide dismutase abolished this effect. Isoflurane and sevoflurane reduced superoxide production of activated neutrophils by 29% and 33%, respectively, and completely prevented the platelet-activating factor-induced increases in neutrophil adherence. Isoflurane at 0.25 MAC blunted, but did not abolish, the neutrophil-induced decreases in left ventricular developed pressure. Conclusion: Neutrophils pretreated with 1.0 MAC isoflurane or sevoflurane lost their ability to cause cardiac dysfunction, while those pretreated with a concentration of isoflurane as low as 0.25 MAC were partially inhibited. This action of the volatile anesthetics was associated with reductions in superoxide production and neutrophil adherence to the coronary vascular endothelium. Our findings suggest that inhibitory actions on neutrophil activation and neutrophil-endothelium interaction may contribute to the preconditioning effects of volatile anesthetics observed in vivo during myocardial ischemia-reperfusion.Keywords
This publication has 25 references indexed in Scilit:
- Mechanisms of Desflurane-induced Preconditioning in Isolated Human Right Atria In VitroAnesthesiology, 2002
- Is Isoflurane-induced Preconditioning Dose Related?Anesthesiology, 2002
- Prevention of Isoflurane-induced Preconditioning by 5-Hydroxydecanoate and GadoliniumAnesthesiology, 2000
- Isoflurane, but not Halothane, Induces Protection of Human Myocardium via Adenosine A1Receptors and Adenosine Triphosphate–sensitive Potassium ChannelsAnesthesiology, 2000
- Sarcolemmal and Mitochondrial Adenosine Triphosphate– dependent Potassium ChannelsAnesthesiology, 2000
- Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft SurgeryCirculation, 1999
- Mechanisms of Isoflurane-induced Myocardial Preconditioning in RabbitsAnesthesiology, 1999
- Anesthetic-induced PreconditioningAnesthesiology, 1997
- Isoflurane Mimics Ischemic Preconditioning via Activation of KATPChannelsAnesthesiology, 1997
- Volatile Anesthetics Protect the Ischemic Rabbit Myocardium from InfarctionAnesthesiology, 1997